- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 14, Issue 6, 2007
Current Medicinal Chemistry - Volume 14, Issue 6, 2007
Volume 14, Issue 6, 2007
-
-
Microscopic Simulation in Biology and Medicine
Authors: Filippo Castiglione, Arcangelo Liso, Massimo Bernaschi and Sauro SucciMathematical models are finding an increasing use in bio-medical scientific investigations as effective means of putting the interpretation of biological phenomena on a more quantitative basis. Besides the well established mathematical paradigm based on differential equations, another approach that takes full advantage of the steadily increasing computing power, is gaining increasing consensus: micro-simulation. Micro- Read More
-
-
-
The Structure and Main Functions of Aminopeptidase N
Authors: Yepeng Luan and Wenfang XuAminopeptidase N (APN)/CD13 is a type II metalloprotease that belongs to the M1 family of the MA clan, which consists of 967 amino acids with a short N-terminal cytoplasmic domain, a single transmembrane part, and a large cellular ectodomain containing the active site. APN has a molecular weight of 110,000. The APN exists in two forms namely the membrane aminopeptidase N and the soluble aminopeptidase N. Read More
-
-
-
The Janus Face of CD4+CD25+ Regulatory T Cells in Cancer and Autoimmunity
Authors: S. Danese and S. RutellaRegulatory T cells (Treg) encompass a heterogeneous family of T cells implicated in maintenance of tolerance to self antigens. Treg cells might be qualitatively and/or quantitatively deficient in human autoimmune diseases, including multiple sclerosis, graft versus host disease, systemic lupus erythematosus, type I diabetes, and rheumatoid arthritis. In animal models of autoimmunity, infusion of ex vivo-expanded Treg cells and Read More
-
-
-
Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Authors: S. Vannucchi, M. V. Chiantore, G. Mangino, Z. A. Percario, E. Affabris, G. Fiorucci and G. RomeoInterferon (IFN) was the first cytokine produced by recombinant DNA technology used in wide-spread clinical treatment of infectious diseases as well as malignancies. The IFN clinical potential was clearly realized from the outset. However, IFN represents one of the most controversial drugs of our time, as remarkable cycles of promise and disappointment have affected its development and use. Considerable evidence regarding Read More
-
-
-
The Antitumoral Mode of Action of Imiquimod and Other Imidazoquinolines
Authors: Margarete Schon and Michael P. SchonImiquimod, the lead compound of the imidazoquinoline family of nucleoside analogues, has shown good efficacy against a variety of tumors of different origin. The mode of action of imiquimod and related compounds, which we have begun to understand in some detail in recent years, is complex and interesting inasmuch as it appears to comprise several presumably mutually enhancing components. Predominant amongs Read More
-
-
-
Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy
Authors: Junkang Xu, Hui Peng and Jian Ting ZhangHuman ABCG2, a member of the ATP-binding cassette transporter superfamily which transports a wide variety of substrates, is highly expressed in placental syncytiotrophoblasts, in the canalicular membranes of liver, in the apical membrane of the small intestine epithelium, and at the luminal surface of the endothelial cells of human brain micro vessels. This strategic tissue localization indicates that ABCG2 plays an important r Read More
-
-
-
Insights into Oxidative Stress: The Isoprostanes
Authors: Paolo Montuschi, Peter Barnes and L. Jackson RobertsOxidative stress, characterized by an imbalance between increased exposure to free radicals and antioxidant defenses, is a prominent feature of many acute and chronic diseases and even the normal aging process. However, definitive evidence for this association has often been lacking due to recognized shortcomings with methods previously available to assess oxidant stress status in vivo in humans. Several in vitro markers Read More
-
-
-
Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Authors: Takayuki Ito, Keiya Ozawa and Kazuyuki ShimadaDuring the last few decades, we have witnessed major improvements in the therapy of pulmonary arterial hypertension (PAH). PAH is characterized by abnormal remodeling of the pulmonary artery (PA) and increased PA pressures, resulting in a high premature mortality. Intravenous epoprostenol was the first effective approach toward improving the symptoms and survival of PAH patients. New prostanoids have also Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
